v3.23.1
Condensed Balance Sheets (Unaudited) - USD ($)
$ in Thousands
Mar. 31, 2023
Dec. 31, 2022
Current assets:    
Cash and cash equivalents $ 62,472 $ 47,254
Marketable securities 188,994 255,090
Investment in equity securities 25,028 32,020
Accounts receivable 9,873 7,122
Prepaid expenses and other current assets 17,696 11,667
Total current assets 304,063 353,153
Property and equipment, net 24,029 24,621
Operating lease right-of-use assets 25,802 26,443
Other non-current assets 3,250 1,855
Restricted cash 872 872
Total assets 358,016 406,944
Current liabilities:    
Accounts payable 5,058 4,797
Accrued compensation 6,356 13,142
Deferred revenue—current 17,186 16,759
Operating lease liability - current 5,251 4,585
Debt—current 13,242 12,500
Accrued expenses and other current liabilities 12,393 14,764
Total current liabilities 59,486 66,547
Deferred revenue - non-current 85,046 89,885
Operating lease liability - non-current 28,071 29,574
Debt—non-current   3,771
Other non-current liabilities   119
Total liabilities 172,603 189,896
Commitments and contingencies (Note 7)
Stockholders’ equity:    
Preferred stock, $0.001 par value -10,000,000 shares authorized as of March 31, 2023 and December 31, 2022; 0 shares issued and outstanding as of March 31, 2023 and December 31, 2022
Common stock, $0.001 par value - 300,000,000 shares authorized as of March 31, 2023 and December 31, 2022; 60,161,801 and 57,499,541 shares issued and outstanding as of March 31, 2023 and December 31, 2022, respectively 60 58
Additional paid-in-capital 688,125 670,223
Accumulated other comprehensive loss (107) (618)
Accumulated deficit (502,665) (452,615)
Total stockholders’ equity 185,413 217,048
Total Liabilities and Stockholders’ Equity $ 358,016 $ 406,944

Source

PDF HTML
10-Q Filing
ZIP XLS HTML
XBRL